reboxetine has been researched along with 5,7-dihydroxytryptamine in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (5,7-dihydroxytryptamine) | Trials (5,7-dihydroxytryptamine) | Recent Studies (post-2010) (5,7-dihydroxytryptamine) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 1,278 | 0 | 55 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, JD; Ferguson, AR; Irvine, KA; Sahbaie, P | 1 |
1 other study(ies) available for reboxetine and 5,7-dihydroxytryptamine
| Article | Year |
|---|---|
Loss of diffuse noxious inhibitory control after traumatic brain injury in rats: A chronic issue.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Uptake Inhibitors; Animals; Brain Injuries, Traumatic; Capsaicin; Chronic Pain; Diffuse Noxious Inhibitory Control; Duloxetine Hydrochloride; Male; Neural Pathways; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2020 |